We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-2.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$34.1B
AUM Growth
-$2.63B
(-7.2%)
Cap. Flow
-$362M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
13.14%
Holding
2,315
New
186
Increased
813
Reduced
981
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$283M |
| 2 |
Medtronic
MDT
|
+$96M |
| 3 |
Philip Morris
PM
|
+$80.4M |
| 4 |
United Parcel Service
UPS
|
+$75.5M |
| 5 |
Dominion Energy
D
|
+$74.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$178M |
| 2 |
General Mills
GIS
|
+$158M |
| 3 |
ExxonMobil
XOM
|
+$138M |
| 4 |
ServiceNow
NOW
|
+$96M |
| 5 |
Keysight
KEYS
|
+$72.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Financials | 15.14% |
| 3 | Technology | 13.55% |
| 4 | Consumer Discretionary | 8.1% |
| 5 | Consumer Staples | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
SouthState Bank Corp
SSB
$10.1B
| $3.88M | 0.01% |
49,082
+15,557
| +46% | +$1.25M |
|
|
BLUE
727
DELISTED
bluebird bio
BLUE
| $3.88M | 0.01% |
30,619
-27,247
| -47% | -$3.08M |
|
728
SunCoke Energy
SXC
$816M
| $3.86M | 0.01% |
664,788
-101,368
| -13% | -$681K |
|
729
Surgery Partners
SGRY
$1.82B
| $3.85M | 0.01% |
164,424
-349,794
| -68% | -$11.2M |
|
730
Stagwell
STGW
$2.04B
| $3.85M | 0.01% |
553,358
+47,405
| +9% | +$306K |
|
731
Aptiv
APTV
$9B
| $3.83M | 0.01% |
48,930
-888
| -2% | -$85.2K |
|
732
LyondellBasell Industries
LYB
$21B
| $3.8M | 0.01% |
50,529
-2,969
| -6% | -$251K |
|
733
Red Rock Resorts
RRR
$3.15B
| $3.79M | 0.01% |
110,698
-8,355
| -7% | -$317K |
|
|
SYNH
734
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $3.78M | 0.01% |
80,173
+34,086
| +74% | +$2.2M |
|
735
Boyd Gaming
BYD
$5.49B
| $3.77M | 0.01% |
79,112
+4,461
| +6% | +$239K |
|
736
Lyell Immunopharma
LYEL
$264M
| $3.76M | 0.01% |
25,660
| – | – |
|
737
HCA Healthcare
HCA
$93.2B
| $3.74M | 0.01% |
20,338
+7,173
| +54% | +$1.43M |
|
738
Match Group
MTCH
$10B
| $3.73M | 0.01% |
78,070
+62,356
| +397% | +$3.92M |
|
739
Shutterstock
SSTK
$183M
| $3.72M | 0.01% |
74,190
+24,816
| +50% | +$1.42M |
|
740
Yext
YEXT
$632M
| $3.7M | 0.01% |
828,780
+33,694
| +4% | +$156K |
|
741
Crown Holdings
CCK
$12.2B
| $3.68M | 0.01% |
45,455
-190,302
| -81% | -$17.7M |
|
|
KNTE
742
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $3.68M | 0.01% |
307,800
| – | – |
|
743
Dynatrace
DT
$16B
| $3.65M | 0.01% |
104,757
+73,535
| +236% | +$2.84M |
|
744
PTC Therapeutics
PTCT
$5.64B
| $3.64M | 0.01% |
+72,477
| New | +$3.55M |
|
745
Lowe's Companies
LOW
$109B
| $3.6M | 0.01% |
19,146
+2,802
| +17% | +$546K |
|
746
Voyager Therapeutics
VYGR
$188M
| $3.59M | 0.01% |
605,795
-7,252
| -1% | -$46.4K |
|
747
Goodyear
GT
$1.49B
| $3.56M | 0.01% |
352,588
+150,494
| +74% | +$1.91M |
|
748
MaxLinear
MXL
$6.3B
| $3.56M | 0.01% |
109,049
-106,178
| -49% | -$3.93M |
|
|
SCU
749
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $3.55M | 0.01% |
401,803
+51,059
| +15% | +$473K |
|
|
AIV
750
Aimco
AIV
$327M
| $3.51M | 0.01% |
+481,005
| New | +$3.95M |
|
Similar funds
Federated Hermes's Q3 2022 Portfolio in Review
As of Q3 2022, Federated Hermes held 2,315 positions worth $34.1B, down 7.2% from $36.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q3 2022 filing shows 186 new, 813 increased, 981 reduced and 182 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M. The largest sale was Cardinal Health, an estimated $178M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q3 2022 buy was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M.
- Federated Hermes added most to JPMorgan Chase in Q3 2022, an estimated $283M increase.
- Federated Hermes's biggest Q3 2022 reduction was Cardinal Health, cutting an estimated $178M.
- Federated Hermes fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $69.1M.
- Federated Hermes's ten largest holdings make up 13% of its $34.1B portfolio in Q3 2022.
- Federated Hermes opened 186 new positions and closed 182 in Q3 2022.
- Federated Hermes's portfolio value fell 7.2% quarter-over-quarter to $34.1B.
Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.